3rd Edition of International Heart Congress
June 05-07,2025 | Hybrid Event
Lipid Lowering Therapy
Lipid Lowering Therapy, a crucial component in cardiovascular health, focuses on managing and reducing elevated levels of cholesterol and triglycerides in the bloodstream. This therapeutic approach plays a pivotal role in preventing and mitigating cardiovascular diseases, such as heart attacks and strokes. Often involving medications known as statins, fibrates, or cholesterol absorption inhibitors, Lipid Lowering Therapy aims to regulate lipid levels and promote overall cardiovascular well-being. Alongside lifestyle modifications such as a heart-healthy diet and regular exercise, this therapeutic strategy is instrumental in addressing one of the primary risk factors for cardiovascular complications. Regular monitoring and personalized treatment plans contribute to the effectiveness of Lipid Lowering Therapy, underscoring its significance in the comprehensive management of cardiovascular health.
Yong Xiao Wang
Albany Medical College, United States
Thomas Bernd Dschietzig
Relaxera GmbH & Co. KG, Germany
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Federico Benetti
Benetti Foundation, Argentina
Johannes Bonatti
University of Pittsburgh, United States
Eric J Lehr
Cherry Hill Campus, United States
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian FederationSubmit your abstract Today
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain
Title : Innovative mechanisms, consequences and therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Comprehensive surgical revascularization for rapidly worsening ischemic heart failure
Deepak Puri, Max Healthcare, India